2012
B-lymphocyte Subpopulations in Patients with Selective IgA Deficiency
NECHVÁTALOVÁ, Jana; Zdenka PIKULOVÁ; Dagmar STIKAROVSKÁ; Sáva PEŠÁK; Marcela VLKOVÁ et al.Základní údaje
Originální název
B-lymphocyte Subpopulations in Patients with Selective IgA Deficiency
Autoři
NECHVÁTALOVÁ, Jana; Zdenka PIKULOVÁ; Dagmar STIKAROVSKÁ; Sáva PEŠÁK; Marcela VLKOVÁ a Jiří LITZMAN
Vydání
Journal of Clinical Immunology, 2012, 0271-9142
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30300 3.3 Health sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.382
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/12:00059958
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
IgA deficiency . common variable immunodeficiency . B-lymphocyte subpopulations
Příznaky
Mezinárodní význam
Změněno: 3. 4. 2013 11:53, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Selective deficiency IgA (IgAD) is the most common primary abnormality of immunoglobulin production with unknown pathophysiology. It is genetically related to common variable immunodeficiency (CVID), where besides IgA also IgG and frequently IgM serum levels are decreased. In this study we focused on determination of B-lymphocyte developmental stages and searching for similarities between CVID and IgAD. Materials and Methods Using flow cytometry we determined major lymphocyte subpopulations and Blymphocyte subsets: naive (CD27-IgD+), marginal zone cells (CD27+IgD+), class-switched memory cells (CD27+IgD-), “double-negative” B cells (CD27-IgD-), transitional cells (IgM++CD38++), plasmablasts (CD38+++IgM+ or IgM-), and CD21lowCD38low cells in 80 patients with IgAD, 48 patients with CVID, and 80 control persons. Results Compared to healthy controls, a decrease in the absolute number and frequency of CD4+ cells (both<0.001) was observed in IgAD patients. A decrease in the frequency of switched memory cells (P<0.001), transitional cells (P00.035) as well as plasmablasts (P<0.001) and an increase in the CD21lowCD38low subset (P00.007) was observed in IgAD patients compared to control persons. No significant differences were observed in the remaining B-cell developmental subsets. A decrease in CD27+IgD- (<0.4% of peripheral blood lymphocytes), frequently observed in CVID patients and also previously reported in IgAD, was found in only five patients (6%) with IgAD, two of them being firstdegree relatives of CVID patients. Conclusion Our results show a decrease of terminally differentiated B-lymphocyte subsets in patients with IgAD, similar as previously found in patients with CVID, but these results are less expressed than in CVID patients.